A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus

Phase 1 Terminated 33 enrolled Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

RandomizedSingle-groupDouble-blindTreatment

Summary

This study will assess the safety, tolerability, pharmacokinetics (explores what the body does to the drug), and pharmacodynamics (explores what a drug does to the body) of multiple doses of JNJ-38431055 in volunteers with type 2 diabetes mellitus.

Timeline

Start: 2009-07
Primary completion: —
Completion: 2009-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ADP-597	Small molecule	—	—

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus

Summary

Timeline

Drugs

Indications